Current screen based on the alphascreen™ technology for deciphering cell signalling pathways

Current Genomics

Volumn 10, Issue 2, 2009, Pages 93-101

  Taouji, Saïd ^a,b   Dahan, Sophie ^c   Bossé, Roger ^c   Chevet, Eric ^a,b  

^a Avenir   (Canada)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c PerkinElmer BioSignal   (Canada)

Author keywords

Alphascreen ; Signal; Signal transduction

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATASE; JANUS KINASE; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR PROTEIN; PROTEIN KINASE; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ENZYME ACTIVITY; ENZYME LOCALIZATION; GENE FUNCTION; GENE INTERACTION; GENE REGULATORY NETWORK; GENE TECHNOLOGY; GENETIC SCREENING; HIGH THROUGHPUT SCREENING; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 65949124866     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920209787847041     Document Type: Review

References (58)

1. Ullman, E.F., Kirakossian, H., Singh, S., Wu, Z.P., Irvin, B.R., Pease, J.S., Switchenko, A.C., Irvine, J.D., Dafforn, A., Skold, C.N., Wagner, D.B. Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. Proc. Natl. Acad. Sci. USA 1994, 91: 5426-5430.
2. Ullman, E.F., Kirakossian, H., Switchenko, A.C., Ishkanian, J., Ericson, M., Wartchow, C.A., Pirio, M., Pease, J., Irvin, B.R., Singh, S., Singh, R., Patel, R., Dafforn, A., Davalian, D., Skold, C., Kurn, N., Wagner, D.B. Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method. Clin. Chem. 1996, 42: 1518-1526.
3. Marchese, A., George, S.R., Kolakowski, L.F., Lynch, K.R., O'Dowd, B.F. Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology. Trends Pharmacol. Sci. 1999, 20: 370-375.
4. Uhlenbrock, K., Gassenhuber, H., Kostenis, E. Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cell. Signal. 2002, 14: 941-953.
5. Fukushima, N., Weiner, J.A., Kaushal, D., Contos, J.J., Rehen, S.K., Kingsbury, M.A., Kim, K.Y., Chun, J. Lysophosphatidic acid influences the morphology and motility of young, postmitotic cortical neurons. Mol. Cell Neurosci. 2002, 20: 271-282.
6. Moolenaar, W.H. Lysophosphatidic acid signalling. Curr. Opin. Cell Biol. 1995, 7: 203-210.
7. Hecht, J.H., Weiner, J.A., Post, S.R., Chun, J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 1996, 135: 1071-1083.
8. Lee, C.W., Rivera, R., Dubin, A.E., Chun, J. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation. J. Biol. Chem. 2007, 282: 4310-4317.
9. Noguchi, K., Ishii, S., Shimizu, T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 2003, 278: 25600-25606.
10. Wilson, J., Rossi, C.P., Carboni, S., Fremaux, C., Perrin, D., Soto, C., Kosco-Vilbois, M., Scheer, A. A homogeneous 384-well high-throughput binding assay for a TNF receptor using alphascreen technology. J. Biomol. Screen 2003, 8: 522-532.
11. Gilman, A.G. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 1987, 56: 615-649.
12. Hanoune, J., Defer, N. Regulation and role of adenylyl cyclase isoforms. Annu. Rev. Pharmacol. Toxicol. 2001, 41: 145-174.
13. Patel, T.B., Du, Z., Pierre, S., Cartin, L., Scholich, K. Molecular biological approaches to unravel adenylyl cyclase signaling and function. Gene 2001, 269: 13-25.
14. Gabriel, D., Vernier, M., Pfeifer, M.J., Dasen, B., Tenaillon, L., Bouhelal, R. High throughput screening technologies for direct cyclic AMP measurement. Assay Drug. Dev. Technol. 2003, 1: 291-303.
15. Williams, C. cAMP detection methods in HTS: selecting the best from the rest. Nat. Rev. Drug Discov. 2004, 3: 125-135.
16. Johnston, P. Cellular assays in HTS. Methods Mol. Biol. 2002, 190: 107-116.
17. Johnston, P.A. Cellular platforms for HTS: three case studies. Drug Discov. Today 2002, 7: 353-363.
18. Pope, A.J., Hertzberg, R. HTS 2010: A Retrospective Look at Screening in the First Decade of the New Millennium. J. Biomol. Screen 1999, 4: 231-234.
19. Thomsen, W., Frazer, J., Unett, D. Functional assays for screening GPCR targets. Curr. Opin. Biotechnol. 2005, 16: 655-665.
20. Carter, P.H., Schipani, E. The roles of parathyroid hormone and calcitonin in bone remodeling: prospects for novel therapeutics. Endocr. Metab. Immun. Disord. Drug Targets 2006, 6: 59-76.
21. Gray, A., Olsson, H., Batty, I.H., Priganica, L., Peter Downes, C. Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts. Anal. Biochem. 2003, 313: 234-245.
22. Camps, M., Ruckle, T., Ji, H., Ardissone, V., Rintelen, F., Shaw, J., Ferrandi, C., Chabert, C., Gillieron, C., Francon, B., Martin, T., Gretener, D., Perrin, D., Leroy, D., Vitte, P.A., Hirsch, E., Wymann, M.P., Cirillo, R., Schwarz, M.K., Rommel, C. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med. 2005, 11: 936-943.
23. Vanhaesebroeck, B., Leevers, S.J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P.C., Woscholski, R., Parker, P.J., Waterfield, M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 2001, 70: 535-602.
24. Engelman, J.A., Luo, J., Cantley, L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 2006, 7: 606-619.
25. Lemmon, M.A. Pleckstrin homology (PH) domains and phosphoinositides. Biochem. Soc. Symp. 2007, 81-93.
26. Vanhaesebroeck, B., Alessi, D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 2000, 346(Pt 3): 561-576.
27. Caruso, M.E., Jenna, S., Beaulne, S., Lee, E.H., Bergeron, A., Chauve, C., Roby, P., Rual, J.F., Hill, D.E., Vidal, M., Bosse, R., Chevet, E. Biochemical clustering of monomeric GTPases of the Ras superfamily. Mol. Cell Proteomics 2005, 4: 936-944.
28. Cohen, P. The regulation of protein function by multisite phosphorylation--a 25 year update. Trends Biochem. Sci. 2000, 25: 596-601.
29. Olsen, J.V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., Mann, M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127: 635-648.
30. Shults, M.D., Janes, K.A., Lauffenburger, D.A., Imperiali, B. A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates. Nat. Methods 2005, 2: 277-283.
31. Guenat, S., Rouleau, N., Bielmann, C., Bedard, J., Maurer, F., Allaman-Pillet, N., Nicod, P., Bielefeld-Sevigny, M., Beckmann, J.S., Bonny, C., Bosse, R., Roduit, R. Homogeneous and nonradioactive high-throughput screening platform for the characterization of kinase inhibitors in cell lysates. J. Biomol. Screen 2006, 11: 1015-1026.
32. Li, Y., Choi, M., Suino, K., Kovach, A., Daugherty, J., Kliewer, S.A., Xu, H.E. Structural and biochemical basis for selective repression of the orphan nuclear receptor liver receptor homolog 1 by small heterodimer partner. Proc. Natl. Acad. Sci. USA 2005, 102: 9505-9510.
33. Li, Y., Cummings, R.T., Cunningham, B.R., Chen, Y., Zhou, G. Homogeneous assays for adenosine 5'-monophosphate-activated protein kinase. Anal. Biochem. 2003, 321: 151-156.
34. Von Leoprechting, A., Kumpf, R., Menzel, S., Reulle, D., Griebel, R., Valler, M.J., Buttner, F.H. Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform. J. Biomol. Screen 2004, 9: 719-725.
35. Warner, G., Illy, C., Pedro, L., Roby, P., Bosse, R. AlphaScreen kinase HTS platforms. Curr. Med. Chem. 2004, 11: 721-730.
36. Rininsland, F., Xia, W., Wittenburg, S., Shi, X., Stankewicz, C., Achyuthan, K., McBranch, D., Whitten, D. Metal ion-mediated polymer superquenching for highly sensitive detection of kinase and phosphatase activities. Proc. Natl. Acad. Sci. USA 2004, 101: 15295-15300.
37. Roduit, R., Schorderet, D.F. MAP kinase pathways in UV-induced apoptosis of retinal pigment epithelium ARPE19 cells. Apoptosis 2008, 13: 343-353.
38. Binder, C., Lafayette, A., Archibeque, I., Sun, Y., Plewa, C., Sinclair, A., Emkey, R. Optimization and Utilization of the SureFire Phospho-STAT5 Assay for a Cell-Based Screening Campaign. Assay Drug Dev. Technol. 2008, 6: 27-37.
39. Yoshimura, A., Naka, T., Kubo, M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 2007, 7: 454-465.
40. Greenhalgh, C.J., Rico-Bautista, E., Lorentzon, M., Thaus, A.L., Morgan, P.O., Willson, T.A., Zervoudakis, P., Metcalf, D., Street, I., Nicola, N.A., Nash, A.D., Fabri, L.J., Norstedt, G., Ohlsson, C., Flores-Morales, A., Alexander, W.S., Hilton, D.J. SOCS2 negatively regulates growth hormone action in vitro and in vivo. J. Clin. Invest. 2005, 115: 397-406.
41. Osmond, R.I., Sheehan, A., Borowicz, R., Barnett, E., Harvey, G., Turner, C., Brown, A., Crouch, M.F., Dyer, A.R. GPCR screening via ERK 1/2: a novel platform for screening G protein-coupled receptors. J. Biomol. Screen 2005, 10: 730-737.
42. Hearps, A.C., Jans, D.A. HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta-dependent mechanism. Biochem. J. 2006, 398: 475-484.
43. Wagstaff, K.M., Jans, D.A. Intramolecular masking of nuclear localization signals: analysis of importin binding using a novel AlphaScreen-based method. Anal. Biochem. 2006, 348: 49-56.
44. Bartholomeeusen, K., De Rijck, J., Busschots, K., Desender, L., Gijsbers, R., Emiliani, S., Benarous, R., Debyser, Z., Christ, F. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75. J. Mol. Biol. 2007, 372: 407-421.
45. Maertens, G., Cherepanov, P., Debyser, Z., Engelborghs, Y., Engelman, A. Identification and characterization of a functional nuclear localization signal in the HIV-1 integrase interactor LEDGF/p75. J. Biol. Chem. 2004, 279: 33421-33429.
46. De Rijck, J., Vandekerckhove, L., Gijsbers, R., Hombrouck, A., Hendrix, J., Vercammen, J., Engelborghs, Y., Christ, F., Debyser, Z. Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication. J. Virol. 2006, 80: 11498-11509.
47. Hombrouck, A., De Rijck, J., Hendrix, J., Vandekerckhove, L., Voet, A., De Maeyer, M., Witvrouw, M., Engelborghs, Y., Christ, F., Gijsbers, R., Debyser, Z. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV. PLoS Pathog. 2007, 3: e47.
48. Al-Mawsawi, L.Q., Christ, F., Dayam, R., Debyser, Z., Neamati, N. Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis. FEBS Lett. 2008, 582: 1425-1430.
49. Baes, M., Gulick, T., Choi, H.S., Martinoli, M.G., Simha, D., Moore, D.D. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell Biol. 1994, 14: 1544-1552.
50. Wei, X., Sasaki, M., Huang, H., Dawson, V.L., Dawson, T.M. The orphan nuclear receptor, steroidogenic factor 1, regulates neuronal nitric oxide synthase gene expression in pituitary gonadotropes. Mol. Endocrinol. 2002, 16: 2828-2839.
51. Xu, Y., Fang, F., Chu, Y., Jones, D., Jones, G. Activation of transcription through the ligand-binding pocket of the orphan nuclear receptor ultraspiracle. Eur. J. Biochem. 2002, 269: 6026-6036.
52. Suzawa, M., Ingraham, H.A. The herbicide atrazine activates endocrine gene networks via non-steroidal NR5A nuclear receptors in fish and mammalian cells. PLoS ONE 2008, 3: e2117.
53. Kus, B., Gajadhar, A., Stanger, K., Cho, R., Sun, W., Rouleau, N., Lee, T., Chan, D., Wolting, C., Edwards, A., Bosse, R., Rotin, D. A high throughput screen to identify substrates for the ubiquitin ligase Rsp5. J. Biol. Chem. 2005, 280: 29470-29478.
54. Elagoz, A., Henderson, D., Babu, P.S., Salter, S., Grahames, C., Bowers, L., Roy, M.O., Laplante, P., Grazzini, E., Ahmad, S., Lembo, P.M. A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor. Br. J. Pharmacol. 2004, 141: 37-46.
55. Bley, K.R., Bhattacharya, A., Daniels, D.V., Gever, J., Jahangir, A., O'Yang, C., Smith, S., Srinivasan, D., Ford, A.P., Jett, M.F. RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists. Br. J. Pharmacol. 2006, 147: 335-345.
56. Tolbert, W.D., Daugherty, J., Gao, C., Xie, Q., Miranti, C., Gherardi, E., Woude, G.V., Xu, H.E. A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist. Proc. Natl. Acad. Sci. USA 2007, 104: 14592-14597.
57. Kadkhodayan, S., Elliott, L.O., Mausisa, G., Wallweber, H.A., Deshayes, K., Feng, B., Fairbrother, W.J. Evaluation of assay technologies for the identification of protein-Peptide interaction antagonists. Assay Drug Dev. Technol. 2007, 5: 501-513.
58. Wheeler, D.L., Barrett, T., Benson, D.A., Bryant, S.H., Canese, K., Chetvernin, V., Church, D.M., Dicuccio, M., Edgar, R., Federhen, S., Feolo, M., Geer, L.Y., Helmberg, W., Kapustin, Y., Khovayko, O., Landsman, D., Lipman, D.J., Madden, T.L., Maglott, D.R., Miller, V., Ostell, J., Pruitt, K.D., Schuler, G.D., Shumway, M., Sequeira, E., Sherry, S.T., Sirotkin, K., Souvorov, A., Starchenko, G., Tatusov, R.L., Tatusova, T.A., Wagner, L., Yaschenko, E. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2008, 36: D13-21.